MedTrace Logo

A Pilot Study of Candesartan as a Treatment for Cocaine Dependence

NCT01938664 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2019-09-04

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to see if a drug called Candesartan will help to reduce use of cocaine.

Conditions

  • Cocaine Dependence

Interventions

DRUG

Candesartan with CBT

8 mg, po (by mouth)

OTHER

Placebo with CBT

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Baylor College of Medicine

    lead OTHER

Principal Investigators

  • Thomas Kosten, MD · Baylor College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01938664 on ClinicalTrials.gov